Literature DB >> 22796029

Molecular diagnosis of a laboratory mouse papillomavirus (MusPV).

Joongho Joh1, A Bennett Jenson, Mary Proctor, Arvind Ingle, Kathleen A Silva, Christopher S Potter, John P Sundberg, Shin-je Ghim.   

Abstract

MusPV, a novel papillomavirus (PV) that naturally infects laboratory mice, was isolated and characterized from a colony of NMRI-Foxn1(nu)/Foxn1(nu) (nude) mice in India. Because MusPV may have been missed during routine pathogen screening of mice in colonies worldwide, a variety of detection methods are described to detect MusPV. The clinical and histologic lesions of productive MusPV infections fit PV-associated features, including papillomas, koilocytes within the stratum granulosum of the hyperplastic/acanthotic papillomatous epithelium, and the presence of intranuclear virus particles in koilocytotic cells visualized by electron microscopy. Antiserum against disrupted PV virions, isolated from another species (canine), identified conserved viral antigens in productively infected cells by immunohistochemistry. A rolling circle technique was used to amplify viral circular DNAs followed by endonuclease restriction enzyme digestion to determine the correct size of PV DNA. Consensus PV degenerative primers, My09/11, commonly used to detect many different types of PVs by polymerase chain reaction (PCR), particularly mucosotropic HPVs, also identified MusPV and all rodent PVs tested. Since there was one nucleotide mismatch between the My09/11 primer set and the MusPV template, a new primer set, MusPV-My09/11, was designed to specifically detect MusPV in latent infections and spontaneous MusPV-induced papillomas. Southern blot analysis verified the presence of full size PV DNA in infected tissues. Virus-like particles (VLPs), generated from MusPV L1 genes, provided a substrate for serological testing of naturally and experimentally infected mice. In summary, a series of diagnostic assays were developed and validated to detect MusPV infection in skin tumors and serological response in laboratory mice.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796029     DOI: 10.1016/j.yexmp.2012.07.001

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  20 in total

1.  Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.

Authors:  Jiafen Hu; Lynn R Budgeon; Nancy M Cladel; Karla Balogh; Roland Myers; Timothy K Cooper; Neil D Christensen
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

2.  Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).

Authors:  Aayushi Uberoi; Satoshi Yoshida; Paul F Lambert
Journal:  J Virol Methods       Date:  2017-12-15       Impact factor: 2.014

Review 3.  DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.

Authors:  Nicholas D Weber; Martine Aubert; Chung H Dang; Daniel Stone; Keith R Jerome
Journal:  Virology       Date:  2014-01-31       Impact factor: 3.616

4.  Systematic evaluation of skin and adnexa in mutant laboratory mice.

Authors:  Kathleen A Silva; Victoria E Kennedy; John P Sundberg
Journal:  Curr Protoc Mouse Biol       Date:  2014-09-03

5.  EXPRESSION OF E8^E2 IS REQUIRED FOR WART FORMATION BY MOUSE PAPILLOMAVIRUS 1 IN VIVO.

Authors:  Frank Stubenrauch; Elke Straub; Katrin Klein; Daniela Kramer; Thomas Iftner; Margaret Wong; Richard B S Roden
Journal:  J Virol       Date:  2021-01-20       Impact factor: 5.103

6.  Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas.

Authors:  John P Sundberg; Timothy M Stearns; Joongho Joh; Mary Proctor; Arvind Ingle; Kathleen A Silva; Soheil S Dadras; A Bennett Jenson; Shin-je Ghim
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

Review 7.  Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.

Authors:  Megan E Spurgeon; Paul F Lambert
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

8.  Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localization.

Authors:  Alessandra Handisurya; Patricia M Day; Cynthia D Thompson; Christopher B Buck; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

9.  Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1.

Authors:  Alessandra Handisurya; Patricia M Day; Cynthia D Thompson; Michael Bonelli; Douglas R Lowy; John T Schiller
Journal:  PLoS Pathog       Date:  2014-08-14       Impact factor: 6.823

10.  The biology of papillomavirus latency.

Authors:  Gareth Adam Maglennon; John Doorbar
Journal:  Open Virol J       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.